Ezra M Friedberg
Director at Pelthos Therapeutics Inc. (PTHS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $326K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 6SEC | PTHSPelthos Therapeutics Inc. | Sell Plan | 55880,484 held (−1%) | $20.72 | $12K | -1.0% |
| Jul 7SEC | PTHSPelthos Therapeutics Inc. | Sell Plan | 53481,066 held (−1%) | $26.03 | $14K | -21.2% |
| Jul 7SEC | PTHSPelthos Therapeutics Inc. | Sell Plan | 2481,042 held (−0%) | $27.33 | $656 | -25.0% |
| Jun 17SEC | PTHSPelthos Therapeutics Inc. | Sell Plan | 22481,659 held (−0%) | $27.12 | $6K | -24.4% |
| Jun 17SEC | PTHSPelthos Therapeutics Inc. | Sell Plan | 5981,600 held (−0%) | $27.94 | $2K | -26.6% |
| Apr 6SEC | PTHSPelthos Therapeutics Inc. | Sell Plan | 29382,292 held (−0%) | $20.51 | $6K | -0.0% |
| Apr 6SEC | PTHSPelthos Therapeutics Inc. | Sell Plan | 26582,027 held (−0%) | $21.36 | $6K | -4.0% |
| Nov 26SEC | PTHSPelthos Therapeutics Inc. | Sell | 5,99934,001 held (−15%) | $28.00 | $168K | -26.8% |
| Nov 26SEC | PTHSPelthos Therapeutics Inc. | Sell | 2,00032,001 held (−6%) | $28.14 | $56K | -27.1% |
| Nov 26SEC | PTHSPelthos Therapeutics Inc. | Sell | 132,000 held (−0%) | $28.50 | $28 | -28.1% |
| Nov 26SEC | PTHSPelthos Therapeutics Inc. | Sell | 2,00030,000 held (−6%) | $28.01 | $56K | -26.8% |
- Sell
Director Ezra M Friedberg sold $12K of PTHS at $20.72 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Ezra M Friedberg sold $14K of PTHS at $26.03 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Ezra M Friedberg sold $656 of PTHS at $27.33 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Ezra M Friedberg sold $6K of PTHS at $27.12 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Ezra M Friedberg sold $2K of PTHS at $27.94 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Ezra M Friedberg sold $6K of PTHS at $20.51 — pre-scheduled 10b5-1 plan sale.